NYSE - Nasdaq Real Time Price USD
Pfizer Inc. (PFE)
23.19
+0.15
+(0.67%)
As of 11:52:36 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,477,472 | 19 |
| Sales | 2,500 | 1 |
| Net Shares Purchased (Sold) | 1,474,972 | 20 |
| Total Insider Shares Held | 3.24M | -- |
| % Net Shares Purchased (Sold) | 83.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DAMICO JENNIFER B. Officer | Sale at price 25.93 per share. | Direct | 64,825 | Mar 4, 2025 |
| DAMICO JENNIFER B. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
| SUSMAN SALLY Officer | Conversion of Exercise of derivative security at price 31.31 per share. | Direct | 2,667,048 | Feb 27, 2025 |
| FONSECA LIDIA PH.D. Officer | Conversion of Exercise of derivative security at price 31.31 per share. | Direct | 2,274,014 | Feb 27, 2025 |
| LANKLER DOUGLAS M Officer | Conversion of Exercise of derivative security at price 31.31 per share. | Direct | 4,912,977 | Feb 27, 2025 |
| SAHNI PAYAL Officer | Conversion of Exercise of derivative security at price 31.31 per share. | Direct | 596,581 | Feb 27, 2025 |
| MCDERMOTT MICHAEL Officer | Conversion of Exercise of derivative security at price 31.31 per share. | Direct | 1,515,999 | Feb 27, 2025 |
| BOURLA ALBERT Chief Executive Officer | Conversion of Exercise of derivative security at price 31.31 per share. | Direct | 18,248,188 | Feb 27, 2025 |
| DAMICO JENNIFER B. Officer | Conversion of Exercise of derivative security at price 31.31 per share. | Direct | 701,845 | Feb 27, 2025 |
| BOSHOFF CHRISTOFFEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| BOSHOFF CHRISTOFFEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2025 |
| SUSMAN SALLY Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 1,917,997 | Feb 21, 2025 |
| LANKLER DOUGLAS M Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 2,589,310 | Feb 21, 2025 |
| SAHNI PAYAL Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 383,581 | Feb 21, 2025 |
| MCDERMOTT MICHAEL Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 335,641 | Feb 21, 2025 |
| BOSHOFF CHRISTOFFEL Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 263,716 | Feb 21, 2025 |
| BOSHOFF CHRISTOFFEL Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 263,716 | Feb 21, 2025 |
| BOURLA ALBERT Chief Executive Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 7,192,498 | Feb 21, 2025 |
| DAMICO JENNIFER B. Officer | Conversion of Exercise of derivative security at price 30.17 per share. | Direct | 263,716 | Feb 21, 2025 |
| BLAYLOCK RONALD E Director | Purchase at price 25.65 per share. | Direct | 499,072 | Feb 13, 2025 |
| GOTTLIEB SCOTT Director | Purchase at price 28.24 per share. | Direct | 28,240 | Oct 30, 2024 |
| DAMICO JENNIFER B. Officer | Sale at price 28.66 per share. | Direct | 147,714 | Aug 13, 2024 |
| BOSHOFF CHRISTOFFEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2024 |
| DAMICO JENNIFER B. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| DE GERMAY ALEXANDRE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| SUSMAN SALLY Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 1,745,304 | Feb 23, 2024 |
| JOHNSON RADY A Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 804,780 | Feb 23, 2024 |
| LANKLER DOUGLAS M Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 2,617,942 | Feb 23, 2024 |
| SAHNI PAYAL Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 315,148 | Feb 23, 2024 |
| MCDERMOTT MICHAEL Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 339,344 | Feb 23, 2024 |
| BOSHOFF CHRISTOFFEL Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 266,620 | Feb 23, 2024 |
| BOURLA ALBERT Chief Executive Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 3,490,607 | Feb 23, 2024 |
| DAMICO JENNIFER B. Officer | Conversion of Exercise of derivative security at price 27.34 per share. | Direct | 266,620 | Feb 23, 2024 |
| BOSHOFF CHRISTOFFEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 23, 2024 |
| BOSHOFF CHRISTOFFEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 29, 2023 |
| GOTTLIEB SCOTT Director | Purchase at price 26.47 per share. | Direct | 79,401 | Dec 15, 2023 |
Related Tickers
MRK Merck & Co., Inc.
77.34
-0.64%
JNJ Johnson & Johnson
152.62
+0.01%
NVO Novo Nordisk A/S
67.16
-1.48%
LLY Eli Lilly and Company
711.41
-0.53%
BMY Bristol-Myers Squibb Company
46.75
-0.60%
ABBV AbbVie Inc.
183.03
+0.27%
GILD Gilead Sciences, Inc.
106.28
-0.43%
AMGN Amgen Inc.
271.05
-0.31%
GSK GSK plc
38.73
-0.50%
AZN AstraZeneca PLC
70.42
+0.67%